On January 17, the U.S. Department of Health and Human Services (HHS) announced the 15 Part D drugs that will be subject to the second round of price negotiations under the Inflation Reduction Act (IRA). The negotiations are set to occur in 2025, with final prices taking effect in 2027. […]
Recently published results from the latest KFF Health Tracking Poll show that both Medicare and Medicaid continue to be viewed favorably across party lines, including by majorities of Republicans, Democrats, and Independents. Half of respondents in the nationally representative survey say the federal government spends “not enough” on Medicare (51%) […]
This week, the Medicare Rights Center released our annual helpline trends report, Medicare Trends and Recommendations: An Analysis of 2023 Call Data from the Medicare Rights Center’s National Helpline. Drawn from our direct experience with beneficiaries and their caregivers, the report outlines key challenges facing people with Medicare and recommends ways […]
A new report from the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) projects that around 11 million people with Medicare Part D will reach the new $2,000 out-of-pocket cap in 2025, with an average savings of $600 for the year. Once enrollees reach this […]
Annual changes to premiums and cost-sharing, as well as the continued rollout of significant Part D reforms included in the Inflation Reduction Act, can give rise to questions and confusion. Understanding what will be different this year can help beneficiaries better navigate their coverage and access care with fewer disruptions […]
This week, the Centers for Medicare & Medicaid Services (CMS) announced that 23.6 million consumers have signed up for 2025 Affordable Care Act (ACA) Marketplace coverage as of January 4. This is a record number of enrollees and builds on gains in recent years years. Last year, 21.3 million consumers […]
